Phosphoramide mustard (cyclohexanamine)

CAT:
804-HY-137316A-01
Size:
5 mg
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
Phosphoramide mustard (cyclohexanamine) - image 1

Phosphoramide mustard (cyclohexanamine)

  • Description:

    Phosphoramide mustard cyclohexanamine is a biologically active metabolite of Cyclophosphamide (HY-17420), with anticancer activitiy. Phosphoramide mustard cyclohexanamine induces DNA damage[1][2].
  • UNSPSC:

    12352211
  • Hazard Statement:

    H302+H312+H332
  • Target:

    DNA Alkylator/Crosslinker; Drug Metabolite
  • Type:

    Reference compound
  • Related Pathways:

    Cell Cycle/DNA Damage; Metabolic Enzyme/Protease
  • Applications:

    Cancer-programmed cell death
  • Field of Research:

    Cancer
  • Assay Protocol:

    https://www.medchemexpress.com/phosphoramide-mustard-cyclohexanamine.html
  • Purity:

    98.0
  • Solubility:

    H2O : ≥ 50 mg/mL
  • Smiles:

    O=P(N(CCCl)CCCl)(N)O.NC1CCCCC1
  • Molecular Formula:

    C10H24Cl2N3O2P
  • Molecular Weight:

    320.20
  • Precautions:

    H302+H312+H332
  • References & Citations:

    [1]Shanthi Ganesan, et al. Phosphoramide mustard exposure induces DNA adduct formation and the DNA damage repair response in rat ovarian granulosa cells. Toxicol Appl Pharmacol. 2015 Feb 1; 282 (3) : 252–258.|[2]S Genka, et al. Brain and plasma pharmacokinetics and anticancer activities of cyclophosphamide and phosphoramide mustard in the rat. Cancer Chemother Pharmacol. 1990;27 (1) :1-7.
  • Shipping Conditions:

    Blue Ice
  • Storage Conditions:

    -20°C (Powder, protect from light, stored under nitrogen)
  • Scientific Category:

    Reference compound1
  • Clinical Information:

    No Development Reported
  • Citation 01:

    Climacteric. 2025 Jan 10:1-12.|Int J Nanomedicine. 2025 Aug 22:20:10195-10212.|J Funct Foods. 2025 Jun.|Sci Rep. 2024 Aug 16;14 (1) :19008.|Tufts University. 2025.|SSRN. 2024 Mar 21.|Stem Cell Res Ther. 2024 Apr 5;15 (1) :97.
  • CAS Number:

    1566-15-0